Nan Zhang

Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B

Shanfeng Zhang, B. Qiao, W. Qiu, 2021, Cancer cell international.

Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial

P. Sasieni, C. Clarke, R. Neal, 2022, Cancers.

UPLC-Q-TOF/MS-based plasma metabolome to identify biomarkers and time of injury in traumatic brain injured rats

Zhihan Wang, Nan Zhang, Ming Gao, 2021, Neuroreport.

LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.

Dongliang Zhang, Nan Zhang, M. Hua, 2022, The American journal of the medical sciences.

Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR‐383‐5p and regulating KIAA0101

Zhiguang Sun, Nan Zhang, Junfeng Liu, 2022, Thoracic cancer.

Correction to: Blocking circ‑SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR‑338‑3p and regulating LIN28B

Shanfeng Zhang, B. Qiao, W. Qiu, 2022, Cancer cell international.